{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:03:48Z","timestamp":1765285428109,"version":"3.46.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.urolonc.2025.10.007","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:42:47Z","timestamp":1761946967000},"page":"72.e9-72.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improved quality of care for testicular germ cell cancer patients by the implementation of an interdisciplinary testis cancer clinic"],"prefix":"10.1016","volume":"44","author":[{"given":"Nico C.","family":"Grossmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian D.","family":"Fankhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hermanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2025.10.007_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.urolonc.2025.10.007_bib0002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.33999","article-title":"Global patterns in testicular cancer incidence and mortality in 2020","volume":"151","author":"Znaor","year":"2022","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2025.10.007_bib0003","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer","volume":"87","author":"Einhorn","year":"1977","journal-title":"Ann Intern Med"},{"issue":"14","key":"10.1016\/j.urolonc.2025.10.007_bib0004","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.20.03296","article-title":"Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG Update Consortium","volume":"39","author":"Gillessen","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.10.007_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology Guidelines on testicular cancer: 2023 update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"issue":"1\u20132","key":"10.1016\/j.urolonc.2025.10.007_bib0006","first-page":"59","article-title":"Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients","volume":"34","author":"Cathomas","year":"2011","journal-title":"Onkologie"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.007_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.6004\/jnccn.2025.0018","article-title":"NCCN Guidelines\u00ae insights: testicular Cancer, version 2.2025","volume":"23","author":"Gilligan","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.007_bib0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","article-title":"Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oldenburg","year":"2022","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.10.007_bib0009","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1464-410X.1988.tb06388.x","article-title":"Physician-dependent prognostic variables in the management of testicular cancer","volume":"61","author":"Thornhill","year":"1988","journal-title":"Br J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.007_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncr.21602","article-title":"Impact of evidence-based interdisciplinary guidelines on testis cancer management","volume":"106","author":"Schrader","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.10.007_bib0011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2016.07.037","article-title":"The evolving management of patients with clinical stage I seminoma","volume":"98","author":"Matulewicz","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2025.10.007_bib0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clgc.2017.08.018","article-title":"Non-guideline-concordant treatment of testicular cancer is associated with reduced relapse-free survival","volume":"16","author":"Paffenholz","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"3 Pt 1","key":"10.1016\/j.urolonc.2025.10.007_bib0013","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.juro.2016.09.073","article-title":"Adherence to National Comprehensive Cancer Network(R) Guidelines for testicular Cancer","volume":"197","author":"Wymer","year":"2017","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.007_bib0014","first-page":"188","article-title":"Frequency of computed tomography examinations in the follow-up care of testicular cancer patients - an evaluation of patterns of care in Germany","volume":"36","author":"Rusner","year":"2013","journal-title":"Onkologie"},{"issue":"5","key":"10.1016\/j.urolonc.2025.10.007_bib0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.euf.2020.10.005","article-title":"Impact of Non-guideline-directed care on quality of life in testicular cancer survivors","volume":"7","author":"Saoud","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"22","key":"10.1016\/j.urolonc.2025.10.007_bib0016","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/archinternmed.2009.427","article-title":"Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer","volume":"169","author":"Smith-Bindman","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.007_bib0017","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2008.10.005","article-title":"Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography","volume":"181","author":"Tarin","year":"2009","journal-title":"J Urol"},{"issue":"25\u201326","key":"10.1016\/j.urolonc.2025.10.007_bib0018","first-page":"356","article-title":"Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort","volume":"140","author":"Cathomas","year":"2010","journal-title":"Swiss Med Wkly"},{"issue":"9406","key":"10.1016\/j.urolonc.2025.10.007_bib0019","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(04)15433-0","article-title":"Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries","volume":"363","author":"Berrington de Gonz\u00e1lez","year":"2004","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.urolonc.2025.10.007_bib0020","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1200\/JCO.21.01199","article-title":"Imaging modality and frequency in surveillance of stage I seminoma testicular cancer: results from a randomized, phase III, noninferiority trial (TRISST)","volume":"40","author":"Joffe","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.007_bib0021","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1470-2045(18)30099-8","article-title":"Medication overuse in oncology: current trends and future implications for patients and society","volume":"19","author":"Schleicher","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.10.007_bib0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12913-020-4930-3","article-title":"The impact of tumor board on cancer care: evidence from an umbrella review","volume":"20","author":"Specchia","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.urolonc.2025.10.007_bib0023","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.31557\/APJCP.2024.25.7.2475","article-title":"Changes in psychological condition during cancer chemotherapy","volume":"25","author":"Kamimura","year":"2024","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:00:25Z","timestamp":1765285225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1078143925004041"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved quality of care for testicular germ cell cancer patients by the implementation of an interdisciplinary testis cancer clinic","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}